Literature DB >> 19133007

Recurrence of pleomorphic adenoma of the parotid gland--predictive value of cadherin-11 and fascin.

Juergen Brieger1, Anne Duesterhoeft, Christoph Brochhausen, Jan Gosepath, C James Kirkpatrick, Wolf J Mann.   

Abstract

The predictive value of cadherin-11, tenascin, fascin, and mucin-1 as markers for the likelihood of recurrence in pleomorphic adenoma of the parotid gland was examined. In this retrospective study we analysed 20 tumours from16 patients by immunohistochemistry. Staining intensities were measured using a semiquantitative scoring approach; localisation (tumour centre vs border) as well as clinical data were analysed and correlated with follow-up. Cadherin-11 was increased in recurrent tumours. However, no changes of fascin, tenascin or mucin-1 were observed. Cadherin-11 and fascin were increased in primary tumours of patients with later recurrence, with fascin upregulation restricted to the tumour border. In conclusion, cadherin-11 and fascin should be further analysed for their value as markers for later recurrence in pleomorphic adenoma. Our observations might reflect dysregulation of cellular pathways contributing to cellular dissemination, which might potentially result in later recurrence.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19133007     DOI: 10.1111/j.1600-0463.2008.01088.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  11 in total

1.  Application of DTI and ARFI imaging in differential diagnosis of parotid tumours.

Authors:  Jinfen Yu; Yanfei Du; Yong Lu; Weidong Zhang; Dongsheng Zhang; Guangbin Wang; Chuanting Li
Journal:  Dentomaxillofac Radiol       Date:  2016-07-22       Impact factor: 2.419

2.  [Knocking down fascin inhibits cervical cancer cell proliferation and tumorigenesis in nude mice].

Authors:  Xian Li; Shanshan Li; Xinxin Wang; Surong Zhao; Hao Liu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-12-30

3.  Fascin: Invasive filopodia promoting metastasis.

Authors:  Laura M Machesky; Ang Li
Journal:  Commun Integr Biol       Date:  2010-05

4.  Neither expression of VEGF-C/D nor lymph vessel density supports lymphatic invasion as the mechanism responsible for local spread of recurrent salivary pleomorphic adenoma.

Authors:  R Salzman; I Stárek; L Kučerová; A Skálová; J Hoza
Journal:  Virchows Arch       Date:  2014-01       Impact factor: 4.064

5.  Downregulation of S100A4 expression by RNA interference suppresses cell growth and invasion in human colorectal cancer cells.

Authors:  Liyong Huang; Ye Xu; Guoxiang Cai; Zuqing Guan; Sanjun Cai
Journal:  Oncol Rep       Date:  2011-12-20       Impact factor: 3.906

6.  Expression Level of Genes Coding for Cell Adhesion Molecules of Cadherin Group in Colorectal Cancer Patients.

Authors:  Zbigniew Lorenc; Mieszko Norbert Opiłka; Celina Kruszniewska-Rajs; Antoni Rajs; Dariusz Waniczek; Małgorzata Starzewska; Justyna Lorenc; Urszula Mazurek
Journal:  Med Sci Monit       Date:  2015-07-13

Review 7.  Why Do Parotid Pleomorphic Adenomas Recur? A Systematic Review of Pathological and Surgical Variables.

Authors:  Pavel Dulguerov; Jelena Todic; Marc Pusztaszeri; Naif H Alotaibi
Journal:  Front Surg       Date:  2017-05-15

8.  The prognostic significance of CD44V6, CDH11, and β-catenin expression in patients with osteosarcoma.

Authors:  Zhouming Deng; Guangfeng Niu; Lin Cai; Renxiong Wei; Xiaolei Zhao
Journal:  Biomed Res Int       Date:  2013-07-18       Impact factor: 3.411

9.  Fascin upregulation in primary head and neck squamous cell carcinoma is associated with lymphatic metastasis.

Authors:  Konstantinos Papaspyrou; Christoph Brochhausen; Irene Schmidtmann; Kai Fruth; Haralampos Gouveris; James Kirckpatrick; Wolf Mann; Juergen Brieger
Journal:  Oncol Lett       Date:  2014-03-28       Impact factor: 2.967

10.  Fascin expression in pleomorphic adenoma and mucoepidermoid carcinoma.

Authors:  Sedigheh Rahrotaban; Faezeh Azmoudeh; Seyedeh Mahboubeh Kiyani
Journal:  Dent Res J (Isfahan)       Date:  2014-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.